Delivery Order SPE2DB20D2002-SPE2DB22FL69W
- Not listed
- This federal contract award, valued at $8,009.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,033,991 units of the antibiotic medication Cefdinir 300 mg capsules. The contract has a firm fixed price and an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $7,804 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,492,739 units of the pharmaceutical drug Cefdinir 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award, valued at $2,221.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,942,991 units of the antibiotic medication Cefdinir 300 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's broader Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,277.95 for the supply of CEFDINIR 300 MG CAPSULE 60S to the Defense Logistics Agency Troop Support Medical. The contract has an ultimate completion date of October 19, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award, valued at $2,789.49, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4561112674 - CEFDINIR 300MG CAP 60S, a pharmaceutical product, with a period of performance through June 30, 2023. Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,103.47, is for the delivery of 4567268097 ! CEFDINIR 300 MG CAPSULE 60S. It is a firm fixed-price delivery order with a completion date of February 14, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a $2,066.39 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFDINIR 300 MG CAPSULE 60S, a prescription medication. The contract has a completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of 4564535230 ! CEFDINIR 300 MG CAPSULE 60S, a prescription medication, to the Defense Logistics Agency (DLA). The $1,207.09 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Cefdinir 300mg capsules (60-count units) with a ceiling value of $13,352.55. This firm fixed-price delivery order, which represents a competitive award with no set-aside designation, is scheduled for completion by December 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.66, is for the delivery of CEFDINIR 300 MG CAPSULE 60S. It is a firm fixed-price delivery order contract with a completion date of March 31, 2025. The contract was awarded on March 28, 2025 and does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL69WDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,758.90 firm-fixed-price delivery order is for the supply of 4,558,375,952 units of the medication Cefdinir 300 mg capsules. The award has an ultimate completion date of September 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The contract supports the medical needs of military personnel, veterans, and other federal beneficiaries through the DLA's procurement of essential pharmaceutical and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 9/8/22 |